United States · FDA National Drug Code directory
Edaravone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66794-259_40905b35-f5ad-1c99-e063-6294a90a22d4
- Product NDC
- 66794-259
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Edaravone
- Labeler
- Piramal Critical Care Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240708
- Source listing expiry
- 20261231
Source-listed ingredients
- EDARAVONE — 30 mg/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 POUCH in 1 CARTON (66794-259-64) / 1 BAG in 1 POUCH / 100 mL in 1 BAG · 66794-259-64
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →